1. Home
  2. EXAS vs SJM Comparison

EXAS vs SJM Comparison

Compare EXAS & SJM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • SJM
  • Stock Information
  • Founded
  • EXAS 1995
  • SJM 1897
  • Country
  • EXAS United States
  • SJM United States
  • Employees
  • EXAS N/A
  • SJM N/A
  • Industry
  • EXAS Medical Specialities
  • SJM Packaged Foods
  • Sector
  • EXAS Health Care
  • SJM Consumer Staples
  • Exchange
  • EXAS Nasdaq
  • SJM Nasdaq
  • Market Cap
  • EXAS 10.1B
  • SJM 11.7B
  • IPO Year
  • EXAS N/A
  • SJM N/A
  • Fundamental
  • Price
  • EXAS $48.49
  • SJM $109.09
  • Analyst Decision
  • EXAS Strong Buy
  • SJM Buy
  • Analyst Count
  • EXAS 20
  • SJM 11
  • Target Price
  • EXAS $70.26
  • SJM $116.27
  • AVG Volume (30 Days)
  • EXAS 2.6M
  • SJM 2.2M
  • Earning Date
  • EXAS 08-06-2025
  • SJM 08-27-2025
  • Dividend Yield
  • EXAS N/A
  • SJM 3.96%
  • EPS Growth
  • EXAS N/A
  • SJM N/A
  • EPS
  • EXAS N/A
  • SJM N/A
  • Revenue
  • EXAS $2,828,128,000.00
  • SJM $8,726,100,000.00
  • Revenue This Year
  • EXAS $14.61
  • SJM $3.87
  • Revenue Next Year
  • EXAS $12.65
  • SJM $2.24
  • P/E Ratio
  • EXAS N/A
  • SJM N/A
  • Revenue Growth
  • EXAS 11.57
  • SJM 6.69
  • 52 Week Low
  • EXAS $39.97
  • SJM $93.30
  • 52 Week High
  • EXAS $72.83
  • SJM $125.42
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 38.76
  • SJM 60.78
  • Support Level
  • EXAS $48.15
  • SJM $105.03
  • Resistance Level
  • EXAS $53.95
  • SJM $110.33
  • Average True Range (ATR)
  • EXAS 2.10
  • SJM 2.38
  • MACD
  • EXAS -0.51
  • SJM 0.70
  • Stochastic Oscillator
  • EXAS 4.39
  • SJM 87.00

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About SJM The J.M. Smucker Company

J.M. Smucker is a packaged food company that primarily sells through the US retail channel (78% of fiscal 2024 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of Hostess and international (primarily Canada). Retail coffee is its largest category (33% of sales) with brands Folgers and Dunkin'. Pet foods (22% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from consumer foods, primarily peanut butter and jelly, through brands Jif and Smucker's. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.

Share on Social Networks: